48,830
edits
Difference between revisions of "Liposarcoma"
Jump to navigation
Jump to search
→General
(→IHC) |
|||
| Line 35: | Line 35: | ||
*Most common malignant sarcoma in the retroperitoneum. | *Most common malignant sarcoma in the retroperitoneum. | ||
*Not all (large) retroperitoneal adipocytic tumours are liposarcomas. | *Not all (large) retroperitoneal adipocytic tumours are liposarcomas. | ||
*Prognosis - good-to-poor dependent on stage. | |||
**AJCC 6th staging: stage I = 96%, stage II = 58% stage III = 42%.<ref name=pmid19101765>{{Cite journal | last1 = Anaya | first1 = DA. | last2 = Lahat | first2 = G. | last3 = Wang | first3 = X. | last4 = Xiao | first4 = L. | last5 = Tuvin | first5 = D. | last6 = Pisters | first6 = PW. | last7 = Lev | first7 = DC. | last8 = Pollock | first8 = RE. | title = Establishing prognosis in retroperitoneal sarcoma: a new histology-based paradigm. | journal = Ann Surg Oncol | volume = 16 | issue = 3 | pages = 667-75 | month = Mar | year = 2009 | doi = 10.1245/s10434-008-0250-2 | PMID = 19101765 }}</ref> | |||
Notes: | Notes: | ||